Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0R2SK
|
||||
Former ID |
DIB007558
|
||||
Drug Name |
Erteberel
|
||||
Synonyms |
LY-500307; SERBA-1; ER beta agonist (BPH), Lilly; Lead estrogen receptor beta agonists (benign prostatic hyperplasia),Eli Lilly
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Prostate hyperplasia [ICD10:N40] | Phase 2 | [524322] | ||
Company |
Eli Lilly & Co
|
||||
Structure |
Download2D MOL |
||||
Formula |
C18H18O3
|
||||
Canonical SMILES |
[C@H]12[C@H](c3c(O[C@H]1c1ccc(cc1)O)ccc(c3)O)CCC2
|
||||
CAS Number |
CAS 533884-09-2
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Estrogen receptor beta | Target Info | Agonist | [549074] | |
KEGG Pathway | Estrogen signaling pathway | ||||
Prolactin signaling pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.